Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹99 | ₹500 |
Expense Ratio | 1.92 | 1.94 |
NAV | ₹37.13 | ₹416.30 |
Fund Started | 11 Jun 2018 | 04 Jun 1999 |
Fund Size | ₹2863.52 Cr | ₹3628.03 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 0.50% if redeemed within 15 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 27.52% | 31.21% |
3 Year | 15.88% | 21.29% |
5 Year | 26.67% | 27.67% |
1 Year
3 Year
5 Year
Equity | 99.21% | 96.55% |
Cash | 0.79% | 3.37% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.84% |
Aurobindo Pharma Ltd. | 7.62% |
Cipla Ltd. | 6.82% |
Dr. Reddy's Laboratories Ltd. | 6.38% |
Lupin Ltd. | 5.99% |
Glenmark Pharmaceuticals Ltd. | 5.70% |
Divi's Laboratories Ltd. | 5.44% |
Apollo Hospitals Enterprise Ltd. | 4.82% |
Krishna Institute of Medical Sciences Ltd | 3.90% |
Torrent Pharmaceuticals Ltd. | 3.55% |
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.00% |
Max Healthcare Institute Ltd. | 6.22% |
Divi's Laboratories Ltd. | 6.05% |
Cipla Ltd. | 5.90% |
Lupin Ltd. | 5.19% |
Lonza Group Ag | 4.16% |
Mankind Pharma Ltd. | 4.15% |
Poly Medicure Ltd. | 3.60% |
Krishna Institute of Medical Sciences Ltd | 3.46% |
Jupiter Life Line Hospitals Ltd. | 3.45% |
Name | Vrijesh Kasera | Tanmaya Desai |
Start Date | 03 Feb 2023 | 27 Jun 2011 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 11 Jun 2018 | 04 Jun 1999 |
Description
Launch Date